Philips v. Garmin: Federal Circuit Affirms Unpatentability of Medical Device Comms Patent
Philips North America, LLC appealed a patentability ruling against US7088233B2, a patent covering a personal medical device communication system and method, with Garmin, Ltd. and Garmin USA, Inc. as respondents. The Federal Circuit affirmed the unpatentability finding in a Rule 36 judgment after 486 days of appellate proceedings.
Federal Circuit closes the door on Philips' medical device comms patent
Philips North America, LLC filed this appeal at the Court of Appeals for the Federal Circuit (Case No. 22-1224) on 6 December 2021, challenging a prior finding that US7088233B2 — directed to a personal medical device communication system and method — was unpatentable. The defendants, Garmin, Ltd. and Garmin USA, Inc., were represented by Paul Hastings, LLP, with Naveen Modi as lead counsel. Philips was represented by Foley & Lardner, LLP through George Christopher Beck.
The case closed on 6 April 2023. The Federal Circuit issued a one-line Rule 36 affirmance — the court's mechanism for affirming a lower tribunal's decision without a written opinion when no new legal question warrants elaboration. The recorded basis of termination is 'Unpatentable'; the docket order states: 'AFFIRMED. See Fed. Cir. R. 36.' The specific reasoning behind the affirmance is not disclosed in the available record beyond the Rule 36 citation.
The 486-day duration is consistent with typical Federal Circuit appeal timelines for patentability disputes routed from inter partes review or similar proceedings. The Rule 36 judgment suggests the court found the lower tribunal's analysis sufficiently thorough to require no further elaboration. Whether Philips pursues en banc rehearing or a certiorari petition to the Supreme Court is not disclosed in the available record.
See Complete Case & Patent Analysis →Filing to Unpatentable in 486 days
486 days from filing to Federal Circuit judgment — a moderately paced appellate proceeding
US7088233B2 — Personal medical device communication system and method
Although US7088233B2 has been confirmed unpatentable in this proceeding, product and legal teams developing personal medical device communication systems, connected health wearables, or remote patient monitoring platforms should not treat this ruling as a blanket clearance. The Philips patent family may include continuation or divisional patents with related claim scope that were not at issue here. Any FTO analysis for products in this space should map the full Philips medical device communication portfolio.
Official order — verbatim text
The Federal Circuit's order — 'AFFIRMED. See Fed. Cir. R. 36.' — confirms the lower tribunal's unpatentability finding without elaborating on its reasoning. Rule 36 affirmances are issued where the court finds the result correct and the legal questions sufficiently settled; they bind the parties and close this appeal, but provide no published analysis of the invalidity grounds or claim construction positions advanced by either side.
Federal Circuit affirms: what the ruling means for both parties
Rule 36 affirmance: lower decision upheld without written opinion
A Federal Circuit Rule 36 affirmance means the court found no reversible error in the tribunal below and that the case presents no novel legal question requiring a written opinion. The lower decision — finding US7088233B2 unpatentable — stands in full. Rule 36 judgments carry full precedential weight for the parties but offer no published reasoning for the broader patent community to analyse.
No reversible error foundPhilips loses: US7088233B2 confirmed unpatentable
For Philips North America, the affirmance extinguishes the claims at issue in US7088233B2 as contested in this proceeding. The patent covering the personal medical device communication system and method cannot be enforced on the terms challenged here. Philips' appellate options at this level are exhausted; further challenge would require en banc rehearing or a petition for certiorari — neither of which is disclosed in the available record.
Patent claims extinguishedGarmin prevails: unpatentability finding survives Federal Circuit review
Garmin, Ltd. and Garmin USA, Inc. secured a clean appellate win: the Federal Circuit declined to disturb the unpatentability ruling. Garmin's personal navigation and wearable device lines that were the subject of this dispute face no further patent enforcement risk from US7088233B2 under the claims adjudicated here. The Rule 36 judgment also provides a final, court-entered record to rely upon in any future related proceedings.
Garmin's position confirmedMedical device communication IP: reduced barrier for wearable tech competitors
The affirmance of unpatentability removes US7088233B2 from the enforceability landscape for personal medical device communication technology. Competitors and product teams working in connected health monitoring, wearable sensors, and personal medical alert systems may find the freedom-to-operate landscape marginally clearer in this specific claim space — though the scope of other Philips patents in adjacent areas is unaffected by this ruling.
FTO landscape clarifiedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Philips North America, LLC | Company | Medical technology company — holder of US7088233B2, personal medical device communication system patentSearch in Eureka ↗ |
| Defendant | Garmin, Ltd. | Company | Garmin, Ltd. and Garmin USA, Inc. — multinational navigation and wearable technology manufacturersSearch in Eureka ↗ |
| Co-Defendant | Garmin, Ltd. | Company | Search in Eureka ↗ |
| Co-Defendant | Garmin USA, Inc. | Company | Search in Eureka ↗ |
| Plaintiff counsel | George Christopher Beck | Attorney | Counsel for Philips North America, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Foley & Lardner, LLP | Law Firm | Representing Philips North America, LLCSearch in Eureka ↗ |
| Defendant counsel | Naveen Modi | Attorney | Counsel for Garmin, Ltd.Search in Eureka ↗ |
| Defendant law firm | Paul Hastings, LLP | Law Firm | Representing Garmin, Ltd.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
R&D signals in the personal medical device communication space
Patent and innovation intelligence derived from the Philips v. Garmin dispute — surfacing portfolio trends, filing activity, and white-space opportunities in connected health communication technology.
Philips' medical device communication filing activity post-2020
With US7088233B2 confirmed unpatentable, understanding Philips North America's broader medical device communication portfolio is critical. Philips has historically filed aggressively in connected health, remote patient monitoring, and hospital telemetry. Mapping active continuations and divisionals sharing priority with US7088233B2 can reveal residual enforcement exposure in the personal medical device communication domain.
Philips portfolio watchPatent filing trends in personal medical device connectivity
The personal medical device communication space — covering wireless data transmission between wearable sensors and external systems — has seen accelerating patent filings driven by remote patient monitoring, smartwatch health features, and IoT medical devices. Understanding the current filing density and key assignees in this claim space helps product teams identify crowded zones and potential validity vulnerabilities in asserted patents.
Connected health filing trendsGarmin's own patent position in health communication technology
Garmin's successful defence of the Philips communication patent challenge suggests it has both the legal resources and technical prior art base to contest medical device IP. Analysing Garmin's own patent filings in health data transmission, biometric sensing, and device-to-network communication reveals how it is building its own offensive and defensive portfolio in the connected health segment.
Garmin health IP portfolioClaim white space near invalidated medical device communication patents
The invalidation of US7088233B2 may create exploitable white space in claim areas adjacent to personal medical device communication systems — particularly around low-power protocols, edge processing of medical sensor data, and secure device-to-cloud transmission architectures. Teams filing in these areas can differentiate from the invalidated claim scope while capturing emerging technical territory.
White space opportunitySimilar Federal Circuit patentability appeals in medical device communication
Explore Federal Circuit appeals involving patentability challenges to personal medical device communication and connected health patents, including comparable Rule 36 affirmances.
What this case signals for the connected health IP landscape
A Rule 36 affirmance of unpatentability at the Federal Circuit sends a clear signal about the durability of legacy medical device communication patents.
Legacy medical device patents face heightened validity scrutiny at the PTAB and on appeal
The affirmance of unpatentability in Philips v. Garmin is consistent with a broader Federal Circuit pattern: older communication-system patents asserted against modern wearable technology are increasingly vulnerable to IPR or similar validity challenges. Patent holders in adjacent connected-health spaces should audit claim scope against current prior art.
Garmin's IPR or PTAB strategy proved durable through full appellate review
Garmin's decision to contest validity rather than design around or license the Philips patent succeeded through Federal Circuit review. For defendants in the wearable and personal medical device segment, this outcome reinforces the viability of a challenge-first posture when faced with broad communication-system patent assertions.
Philips v Garmin — key questions answered
The Federal Circuit affirmed the unpatentability of US7088233B2 in a Rule 36 judgment issued on 6 April 2023. The one-line order — 'AFFIRMED. See Fed. Cir. R. 36.' — confirms the lower tribunal's finding without a written opinion. The recorded basis of termination is 'Unpatentable'. No further reasoning is disclosed in the available record.
US7088233B2 (application number US10/165624) is a Philips North America patent directed to a personal medical device communication system and method. It covers technology enabling a personal medical device to communicate data to an external system or network — claim language broad enough to reach modern connected health wearables and personal monitoring devices.
A Rule 36 judgment means the Federal Circuit affirmed the lower tribunal's decision without issuing a written opinion, having found no reversible error and no novel legal question requiring elaboration. The unpatentability finding stands and is binding on the parties. It provides no published reasoning for the broader patent community to analyse or distinguish in future cases.
The available record characterises the verdict cause as an invalidity/cancellation action on patentability grounds. Garmin, a manufacturer of navigation and wearable health devices, had commercial incentive to contest a broad personal medical device communication patent that could reach its connected fitness and health monitoring product lines. The specific invalidity arguments advanced are not disclosed in the available public record.
The ruling in Case No. 22-1224 is specific to the claims of US7088233B2 as challenged in this proceeding. Whether Philips holds continuation, divisional, or related patents with overlapping claim scope that remain active and enforceable is not addressed by this ruling. Parties operating in the personal medical device communication space should conduct independent portfolio analysis to assess residual risk from related Philips patents.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.